These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34554623)

  • 1. Synergistic Therapy of a Naturally Inspired Glycopolymer-Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability.
    Duan Z; Luo Q; Dai X; Li X; Gu L; Zhu H; Tian X; Zhang H; Gong Q; Gu Z; Luo K
    Adv Mater; 2021 Nov; 33(45):e2104594. PubMed ID: 34554623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging.
    Fang J; Šubr V; Islam W; Hackbarth S; Islam R; Etrych T; Ulbrich K; Maeda H
    Eur J Pharm Biopharm; 2018 Sep; 130():165-176. PubMed ID: 29885851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Platelet-Mimicking Nanovehicles.
    Hu Q; Sun W; Qian C; Wang C; Bomba HN; Gu Z
    Adv Mater; 2015 Nov; 27(44):7043-50. PubMed ID: 26416431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
    Tanaka M; Sasaki M; Suzuki T; Nishie H; Kataoka H
    Biochem Biophys Res Commun; 2021 Feb; 539():1-7. PubMed ID: 33388624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy.
    Wu Y; Li F; Zhang X; Li Z; Zhang Q; Wang W; Pan D; Zheng X; Gu Z; Zhang H; Gong Q; Luo K
    Carbohydr Polym; 2021 Mar; 255():117490. PubMed ID: 33436250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surfactant-like chemotherapeutic agent as a nanocarrier for delivering photosensitizers against cancer: A facile drug-delivering-drug strategy.
    Wang Z; Sun M; Liu T; Tan X; Zhang H; Zhang X; He Z; Sun J
    Int J Pharm; 2019 May; 562():313-320. PubMed ID: 30898641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy.
    Cao B; Xu H; Yang M; Mao C
    Methods Mol Biol; 2018; 1776():643-652. PubMed ID: 29869271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
    Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J
    J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT‑oxygen consumption and hypoxia sensitive chemotherapeutic drug.
    Wang X; Wang Z; Ma W; Wu X; Fang W; Guo C; Jin Y
    J Photochem Photobiol B; 2021 Sep; 222():112274. PubMed ID: 34330082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Light Responsive Imaging-Guided Photothermal and Photodynamic Synergistic Therapy Nanoplatform Based on Carbon Nanohorns for Efficient Cancer Treatment.
    Gao C; Dong P; Lin Z; Guo X; Jiang BP; Ji S; Liang H; Shen XC
    Chemistry; 2018 Sep; 24(49):12827-12837. PubMed ID: 29978545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-Targeted Polyethylene Glycol-Modified Photosensitizers for Photodynamic Therapy.
    Liu Q; Wang J; Li S; Li G; Chen Q; Hong Z
    J Pharm Sci; 2019 Jun; 108(6):2102-2111. PubMed ID: 30677421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycodendron/pyropheophorbide-a (Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy.
    Zhang X; Wu Y; Li Z; Wang W; Wu Y; Pan D; Gu Z; Sheng R; Tomás H; Zhang H; Rodrigues J; Gong Q; Luo K
    Carbohydr Polym; 2020 Nov; 247():116749. PubMed ID: 32829865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin-mediated biomimetic synthesis of paramagnetic O
    Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B
    Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
    Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
    Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment.
    Cai H; Xiang Y; Zeng Y; Li Z; Zheng X; Luo Q; Zhu H; Gong Q; Gu Z; Liu Y; Zhang H; Luo K
    Acta Pharm Sin B; 2021 Feb; 11(2):544-559. PubMed ID: 33643830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.